'Rapid transit' constipation in children: a possible genesis for irritable bowel syndrome

J M Hutson1,2,3, M C Hynes4, I Kearsey4

  • 1Surgical Research Group, Murdoch Children's Research Institute, Melbourne, Australia. john.hutson@rch.org.au.

Insights

Rapid transit constipation (RTC), a pattern in children, may be linked to fructose intolerance. Reducing fructose improved symptoms in many children, suggesting a potential early dietary intervention for constipation and irritable bowel syndrome (IBS).

Area of Science:

  • Pediatric Gastroenterology
  • Dietary Science
  • Functional Gastrointestinal Disorders

Background:

  • Chronic idiopathic constipation (CIC) in children often necessitates surgical intervention after medical treatments fail.
  • Rapid transit constipation (RTC) is a pattern identified in CIC, previously linked to surgical workup.
  • Irritable bowel syndrome (IBS), particularly the constipation-predominant subtype (IBS-C), affects a significant portion of children.

Purpose of the Study:

  • To discuss the pattern of Rapid Transit Constipation (RTC) in children with Chronic Idiopathic Constipation (CIC).
  • To explore the potential link between RTC, fructose intolerance, and Irritable Bowel Syndrome (IBS) in pediatric patients.
  • To investigate the efficacy of dietary fructose restriction in managing RTC symptoms.

Main Methods:

  • Retrospective audit of 1000 nuclear medicine gastrointestinal transit studies (NMGIT) to identify RTC prevalence.
  • Assessment of fructose intolerance using breath tests in children with RTC.
  • Evaluation of symptom improvement (constipation, pain, stool consistency) and laxative use following fructose exclusion diets.

Main Results:

  • RTC was identified in 29% of pediatric NMGIT studies.
  • Children with RTC and positive fructose breath tests showed significant improvement in constipation, abdominal pain, and stool consistency after fructose exclusion.
  • Fructose restriction led to a decrease in laxative use among these patients.

Conclusions:

  • RTC may be associated with fructose intolerance and potentially IBS-C in children.
  • Dietary fructose restriction shows promise as an early treatment for children with RTC, potentially preventing long-term IBS development.
  • These findings suggest a paradigm shift towards early dietary management for pediatric constipation.

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
876
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
692
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
654
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
712
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
580
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
603